The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - GlaxoSmithKline; Roche
Expert Testimony - GlaxoSmithKline; Roche
Travel, Accommodations, Expenses - GlaxoSmithKline; Roche
Fear of progression in patients with low-risk malignant melanoma.
 
Katharina C. Kaehler
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Roche
 
Tobias Wagner
No Relationships to Disclose
 
Christine Blome
Honoraria - Celgene; Lilly
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Celgene; Lilly
 
Andrea Forschner
No Relationships to Disclose
 
Claus Garbe
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Philogen; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Philogen; Roche
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Philogen; Roche
 
Ralf Gutzmer
Honoraria - Almirall; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - Almirall; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; MSD; Novartis; Pierre Fabre; Roche
Research Funding - Johnson & Johnson (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Axel Hauschild
Honoraria - Amgen; Bristol-Myers Squibb; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar; Novartis; OncoSec; Philogen; Provectus; Regeneron; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar Therapeutics, Philogen, Provectus, Regeneron; Novartis; OncoSec; Roche
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; Merck Serono; Merck Sharp & Dohme; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MedImmune; Merck Serono; Merck Sharp & Dohme; Nektar Therapeutics, Philogen, Provectus, Regeneron; Novartis; OncoSec; Roche
 
Lucie Heinzerling
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Amgen (Inst); Bristol-Myers Squibb; Bristol-Myers Squibb (Inst); MSD; MSD (Inst); Novartis; Novartis (Inst); Roche; Roche (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Novartis; Roche
 
Elisabeth Livingstone
Honoraria - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Medac; Merck Serono; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Roche
Speakers' Bureau - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Serono; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; MSD; Novartis
 
Berenice M. Lang
Honoraria - LEO Pharma; Novartis; Roche
Consulting or Advisory Role - LEO Pharma
Travel, Accommodations, Expenses - Celgene; Galderma; Novartis; Pfizer
 
Carmen Loquai
Honoraria - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche
 
Dirk Schadendorf
Honoraria - Agenus; Amgen; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Grunenthal; Immunocore; Incyte; LEO Pharma; Merck Serono; Merck Sharp & Dohme; Novartis; Pfizer; Philogen; Pierre Fabre; Regeneron; Roche/Genentech; Sysmex
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Grunenthal; Immunocore; Merck Serono; Merck Sharp & Dohme; Novartis; Roche/Genentech; Sysmex
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Incyte; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche
Research Funding - Bristol-Myers Squibb (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Roche/Genentech
 
Patrick Terheyden
Honoraria - Bristol-Myers Squibb; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Novartis; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Matthias Augustin
No Relationships to Disclose